hemoglobin A signaling mechanism for growth-related expression of fetal

[1]  M. Gladwin,et al.  Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. , 2003, The Journal of clinical investigation.

[2]  Jeffery L. Miller,et al.  Fetal hemoglobin modulation during human erythropoiesis: stem cell factor has "late" effects related to the expression pattern of CD117. , 2003, Blood.

[3]  Jeffery L. Miller,et al.  Fetal and adult hemoglobin production during adult erythropoiesis: coordinate expression correlates with cell proliferation. , 2002, Blood.

[4]  A. Verma,et al.  Activation of the p38 Mitogen-activated Protein Kinase Mediates the Suppressive Effects of Type I Interferons and Transforming Growth Factor-β on Normal Hematopoiesis* , 2002, The Journal of Biological Chemistry.

[5]  Jeffery L. Miller.  Hemoglobin switching and modulation: genes, cells, and signals , 2002, Current opinion in hematology.

[6]  L. Mahadevan,et al.  Transcription: MAPK-regulated transcription: a continuously variable gene switch? , 2002, Nature Reviews Molecular Cell Biology.

[7]  T. Chin,et al.  Antiproliferative effect of nitric oxide on rat glomerular mesangial cells via inhibition of mitogen-activated protein kinase. , 2001, European journal of biochemistry.

[8]  H. Lodish,et al.  Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. , 2001, Blood.

[9]  M. Ratajczak,et al.  Biological significance of MAPK, AKT and JAK‐STAT protein activation by various erythropoietic factors in normal human early erythroid cells , 2001, British journal of haematology.

[10]  Jianqi Yang,et al.  Sodium Butyrate Induces Transcription from the Gαi2Gene Promoter through Multiple Sp1 Sites in the Promoter and by Activating the MEK-ERK Signal Transduction Pathway* , 2001, The Journal of Biological Chemistry.

[11]  J. Groopman,et al.  Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. , 2001, Blood.

[12]  A. Schechter,et al.  Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease , 2001, Current opinion in hematology.

[13]  Kavita Shah,et al.  ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation , 2001, Nature Cell Biology.

[14]  M. Cappellini,et al.  Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Lavelle,et al.  Effects of hydroxurea, stem cell factor, and erythropoietin in combination on fetal hemoglobin in the baboon. , 2001, Experimental hematology.

[16]  M. Gishizky,et al.  SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.

[17]  W. Kolch.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. , 2000, The Biochemical journal.

[18]  Y Taya,et al.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.

[19]  G. Adler,et al.  TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation , 2000, Oncogene.

[20]  Z. Zhao,et al.  Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways , 2000, British journal of haematology.

[21]  R. Buscà,et al.  Ras mediates the cAMP‐dependent activation of extracellular signal‐regulated kinases (ERKs) in melanocytes , 2000, The EMBO journal.

[22]  C. Peschle,et al.  Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. , 2000, Blood.

[23]  B. Forget.  Molecular Basis of Hereditary Persistence of Fetal Hemoglobin , 1998, Annals of the New York Academy of Sciences.

[24]  T. Jacks,et al.  Nf1 Regulates Hematopoietic Progenitor Cell Growth and Ras Signaling in Response to Multiple Cytokines , 1998, The Journal of experimental medicine.

[25]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[26]  B. Haye,et al.  Activation of Raf-1 and mitogen-activated protein kinases by erythropoietin and inositolphosphate-glycan in normal erythroid progenitor cells: involvement of protein kinase C. , 1997, Cellular signalling.

[27]  M. Freedman,et al.  Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. , 1996, Blood.

[28]  Philip R. Cohen,et al.  PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[29]  C. Peschle,et al.  c-kit ligand reactivates fetal hemoglobin synthesis in serum-free culture of stringently purified normal adult burst-forming unit-erythroid. , 1993, Blood.

[30]  G. Stamatoyannopoulos,et al.  Fetal hemoglobin in acute and chronic states of erythroid expansion. , 1993, Blood.

[31]  D. Williams,et al.  Influence of steel factor on hemoglobin synthesis in sickle cell disease. , 1992, Blood.

[32]  B. Alter,et al.  Adult‘fetal‐like’erythropoiesis characterizes recovery from bone marrow transplantation , 1986, British journal of haematology.

[33]  M. Adinolfi,et al.  Cancer, oncogenes and oncofetal antigens. , 1985, The Quarterly journal of medicine.

[34]  G. Stamatoyannopoulos,et al.  Perturbations in the erythroid marrow progenitor cell pools may play a role in the augmentation of HbF by 5-azacytidine. , 1984, Blood.

[35]  G. Stamatoyannopoulos,et al.  F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. , 1975, Blood.

[36]  J. Edwards,et al.  Haemoglobin and red cell enzyme changes in juvenile myeloid leukaemia. , 1968, British medical journal.